Latest Investments News

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.

EPX Limited reported a net increase in Annual Contract Value to $18 million and a steady rise in Annual Recurring Revenue to $15.7 million for Q3 2025, driven by new contracts in the UAE healthcare sector and Australian commercial properties.

Bapcor reports a 2.7% revenue decline in 1Q26 and outlines a comprehensive operational review and cost-saving plan, setting cautious guidance for FY26.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Noronex Limited has secured a significant earn-in agreement with South32, enabling a A$5 million exploration program at the Cgae Cgae Copper Project in Botswana. This deal expands their strategic alliance and sets the stage for extensive drilling activity in the Kalahari Copper Belt.

Wellnex Life reported an 18.2% sales decline in Q1 FY26 amid delayed IP licensing revenue and increased costs, while securing new debt facilities and exiting the medicinal cannabis segment.

Resolution Minerals secures a $2 million placement from Tribeca Investment Partners, reinforcing its position in the U.S. critical minerals sector and advancing exploration at the strategically important Horse Heaven Project.

Deep Yellow Ltd announces the departure of long-serving CEO John Borshoff, with CFO Craig Barnes stepping in as interim leader while a global search for a successor continues.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

BrainChip Holdings has initiated tape-out for its AKD1500 neuromorphic AI chip, targeting volume production by late Q3 2026 to meet rising demand for ultra-low-power edge AI solutions.